More News

01 Aug 2007 Neuren to obtain late stage compound through Hamilton Pharmaceuticals acquisition
01 Aug 2007 FDA Advisory Panel votes 22 to 1 for Avandia(R) to remain available to patients in the US
01 Aug 2007 Amgen Responds to Final CMS National Coverage Determination on Use of Erythropoiesis-Stimulating Agents in Oncology
28 Jul 2007 Eisai Enters into In-licensing Agreement with Sepracor for Eszopiclone Insomnia Treatment
28 Jul 2007 ReNeuron acquires business assets of AmCyte Inc. for $4m. 27/07/07
28 Jul 2007 Medtronic to Acquire Kyphon for $3.9 Billion
28 Jul 2007 OSI Pharmaceuticals Announces Agreement to Divest Anti-Platelet Derived Growth Factor (PDGF) Program
28 Jul 2007 GlaxoSmithKline and Targacept Form Alliance in Therapeutics for CNS-related Disorders
27 Jul 2007 Exelixis Retains Right to Develop and Commercialize XL647
27 Jul 2007 Hydra Biosciences and Pfizer Global Research & Development
26 Jul 2007 Cell Therapeutics, Inc. (CTI) Announces Agreement to Acquire SMi; Gains Global Rights to Brostallicin, in a New Class of Cancer Killing Agents
26 Jul 2007 Merck & Co., Inc. to Acquire NovaCardia, Inc., to Boost Clinical Pipeline of Cardiovascular Drug Candidates
26 Jul 2007 BioSante Pharmaceuticals Announces Positive Resultsfor its CaP Technology for Use in Aesthetic Medicine
26 Jul 2007 Spectrum Pharmaceuticals Acquires From Indena Worldwide Rights To Ortataxel, A Phase 2 Third Generation Taxane
25 Jul 2007 Kissei Entered into an Agreement with Nuon Therapeutics, Inc on Tranilast (Product Name: Rizaben(R))
25 Jul 2007 Anika Therapeutics Receives FDA Approval for ELEVESS(TM) Product
21 Jul 2007 Caraco Pharmaceutical Laboratories, Ltd. Announces Tentative FDA Approval for Generic Provigil(R)
21 Jul 2007 Kirin and Terumo announce a basic agreement on a business collaboration
20 Jul 2007 Schering-Plough Announces Licensing of Acadesine, an Investigational Agent Being Studied for Prevention of Complications From Cardiac Surgery
20 Jul 2007 Glenmark purchases rights to two therapeutic antibodies from Chromos
20 Jul 2007 Severin Schwan to succeed Franz B. Humer as Chief Executive of the Roche Group at the March 2008 shareholders' meeting
20 Jul 2007 Abraxis BioScience and Biocon Limited Announce Licensing Agreement for G-CSF in North America and the European Union
20 Jul 2007 NUCRYST Pharmaceuticals receives FDA clearance
20 Jul 2007 Bone Medical Phase II Capsitonin(TM) (oral calcitonin)
19 Jul 2007 Merck Transfers Abbott Rights for Niaspan Outside the U.S.

La Merie Biologics

FREE Weekly News Bulletin

2017 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Top